id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
CMS-2012-0083-4753,CMS,CMS-2012-0083,Scanned_document_16-08-2012_16-48-26_Pilotte pages 1-2 pdf,Other,,2014-03-06T05:00:00Z,2014,3,2014-03-06T05:00:00Z,,2014-03-06T19:33:34Z,,0,0,09000064816080b3
CMS-2012-0083-4750,CMS,CMS-2012-0083,CR7397-R2368CP_ATHauswald,Other,,2014-03-06T05:00:00Z,2014,3,2014-03-06T05:00:00Z,,2014-03-06T19:32:43Z,,0,0,09000064816080b0
CMS-2012-0083-4751,CMS,CMS-2012-0083,mm6050,Other,,2014-03-06T05:00:00Z,2014,3,2014-03-06T05:00:00Z,,2014-03-06T19:33:09Z,,0,0,09000064816080b1
CMS-2012-0083-4749,CMS,CMS-2012-0083,CR7109-R2115CP.pdf Tayloe Hauswald,Other,,2014-03-06T05:00:00Z,2014,3,2014-03-06T05:00:00Z,,2014-03-06T19:32:22Z,,0,0,09000064816080af
CMS-2012-0083-4752,CMS,CMS-2012-0083,Scanned_document_05-08-2013_12-34-37. Bryant pdf,Other,,2014-03-06T05:00:00Z,2014,3,2014-03-06T05:00:00Z,,2014-03-06T19:33:22Z,,0,0,09000064816080b2
CMS-2012-0083-4756,CMS,CMS-2012-0083,CMS-1590-P_Index for rulemaking record_DAC_signed,Other,,2014-03-06T00:00:00Z,2014,3,,,2014-03-07T19:09:05Z,,0,1,09000064816080ae
CMS-2012-0083-4754,CMS,CMS-2012-0083,CMS-1590-P_Index for rulemaking record f2f 730 DME,Other,,2014-03-06T00:00:00Z,2014,3,,,2014-03-07T19:06:39Z,,0,1,090000648160808d
CMS-2012-0083-4755,CMS,CMS-2012-0083,CMS-1590-P_Index for rulemaking record Pt B Drugs HAPG-DAS,Other,,2014-03-06T00:00:00Z,2014,3,,,2014-03-07T19:08:22Z,,0,1,09000064816080ad
CMS-2012-0083-4746,CMS,CMS-2012-0083,Addenda 2013 on the Web,Other,,2013-03-15T04:00:00Z,2013,3,2013-03-15T04:00:00Z,,2013-03-15T13:45:52Z,,0,0,090000648122c299
CMS-2012-0083-4747,CMS,CMS-2012-0083,Addenda 2013,Other,,2013-03-15T04:00:00Z,2013,3,2013-03-15T04:00:00Z,,2013-03-15T13:47:15Z,,0,0,090000648122c298